INO Financial Facts
Loss from investment in affiliated entity: -958.14KLicense fee and milestone revenue from affiliated entity: 574.6K
See Full Income Statement
Total assets: 194.55M
Accumulated other comprehensive income: 2.66M
See Full Balance Sheet
Inovio Pharma (INO) Earnings
|
Expand Research on INO
| Next EPS Date | 5/8/24 | EPS Growth Rate | -625.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +55.3% | Revenue Growth Rate | +490.9% |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.84 | N/A | N/A | $650K | N/A | N/A | N/A | ||
| 3/13/24 | Q423 | N/A | -$1.23 | N/A | $103M | $217.65K | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | -$0.09 | -$0.13 | +$0.04 | $390K | $116.67K | N/A |  | | Details | |
| 8/9/23 | Q223 | -$0.13 | -$0.15 | +$0.02 | $230K | $262.5K | N/A | | | Details | |
| 5/10/23 | Q123 | $0.16 | -$0.15 | +$0.31 | $110K | $300K | N/A | | | Details | |
| 3/1/23 | Q422 | -$0.22 | -$0.17 | -$0.05 | $125K | $339.28K | N/A | | | Details | |
| 11/8/22 | Q322 | -$0.29 | -$0.29 | $0.00 | $291.7K | $534K | N/A | | | Details | |
| 8/9/22 | Q222 | -$0.39 | -$0.30 | -$0.09 | $272.82K | $529K | N/A | | | Details |
